Home - Products - Others - Other Targets - Quercetin 3-O-neohesperidoside

Quercetin 3-O-neohesperidoside

CAS No. 32453-36-4

Quercetin 3-O-neohesperidoside( —— )

Catalog No. M31947 CAS No. 32453-36-4

Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 477 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    Quercetin 3-O-neohesperidoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
  • Description
    Quercetin 3-O-neohesperidoside shows anti-atherosclerosis, and antiplatelet aggregation activities.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32453-36-4
  • Formula Weight
    610.5
  • Molecular Formula
    C27H30O16
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DFO

    DFO (9H-1,8-Diazafluoren-9-one) is used to find fingerprints on porous surfaces.1,8-diazafluoren-9-one (DFO) is used in the forensic field to enhance latent fingerprints deposited on porous surfaces due to the formation of fluorescent products by reacting with the amino acids present in the papillary exudate. DFO has been the most used because of its excellent enhancing properties.

  • JK-P3

    JK-P3 is a pyrazole-based inhibitor of VEGFR-2 (IC50: 7.8 μM). JK-P3 inhibits FGFR 1/3 kinase activity in vitro, but has no effect on FGFR signaling in cell-based assays.

  • c(Bua-Cpa-Thi-Val-As...

    c(Bua-Cpa-Thi-Val-Asn-Cys)-Pro-Agm a highly efficient, selective and short-acting peptide V2 receptor agonist (V2R), with EC50s of hV2R and rV2R being 0.25 and 0.05 nM, respectively.